UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 31, 2023
GLUCOTRACK, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 001-41141 | 98-0668934 | ||
| (State or Other Jurisdiction | (Commission | (IRS Employer | ||
| of Incorporation) | File Number) | Identification No.) |
| 8 Ariel Sharon Street, P.O. Box 6037607, Or Yehuda, Israel | L3 7760049 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: 972 (8) 675-7878
N/A
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| Common Stock | GCTK | Nasdaq Capital Market |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR § 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR § 240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders
On March 31, 2023, GlucoTrack, Inc. held its 2022 Annual Meeting of Shareholders. The results of the voting with respect to this Annual Meeting are as set forth below.
| DIRECTORS INFORMATION | ||||||||||||||||
| DIR # | VOTES FOR | VOTES WITHHELD | BROKER NON-VOTE | % VOTES FOR | ||||||||||||
| Dr. Robert Fischell | 2,881,036.00 | 5,250,502.00 | 488,583.00 | 18.58 | ||||||||||||
| Luis Malave | 2,880,918.00 | 5,250,620.00 | 488,583.00 | 18.58 | ||||||||||||
| Andrew Sycoff | 2,945,847.00 | 5,185,691.00 | 488,583.00 | 19.00 | ||||||||||||
| Shimon Rapps | 2,882,073.00 | 5,249,465.00 | 488,583.00 | 18.59 | ||||||||||||
| Allen Danzig | 2,880,916.00 | 5,250,622.00 | 488,583.00 | 18.58 | ||||||||||||
| PROPOSALS INFORMATION | ||||||||||||||||||||
| PROP # | VOTES FOR | VOTES AGAINST | VOTES ABSTAIN | BROKER NON-VOTE | % VOTES FOR | |||||||||||||||
| Ratify Auditor | 8,612,584.00 | 7,481.00 | 56.00 | 0.00 | 55.55 | |||||||||||||||
| Nonbinding Say on Pay | 2,844,095.00 | 5,205,181.00 | 82,262.00 | 488,583.00 | 18.34 | |||||||||||||||
ITEM 9.01 Exhibit
| Exhibit 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: April 6, 2023 | ||
| GLUCOTRACK, INC. | ||
| By: | /s/ Jolie Kahn | |
| Name: | Jolie Kahn | |
| Title: | Chief Financial Officer | |